Peripheral IV Catheters Global Market Report 2024 by The Business Research Company | Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical Inc., Vygon SAS, Terumo Corporation, Teleflex Incorporated, NIPRO Medical Corporation, Argon Medical

The peripheral iv catheters market size has grown strongly in recent years. It will grow from $5.19 billion in 2023 to $5.58 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to growing healthcare facilities, aging population and chronic diseases, surgical and medical procedures, increased hospital admissions, demand for vascular access devices.

The peripheral iv catheters market size is expected to see strong growth in the next few years. It will grow to $7.67 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to minimally invasive procedures and catheters, short peripheral catheters for outpatient care, catheter-related bloodstream infection prevention, expansion of home healthcare, integration of antimicrobial coatings.. Major trends in the forecast period include ultrasound-guided peripheral iv catheter insertion, reduced complications and catheter failure, wireless communication for catheter monitoring, patient-centered catheter care, shift toward disposable catheters.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=6658&type=smp

Peripheral IV Catheters Market Major Segments
The peripheral iv catheters market covered in this report is segmented -

1) By Product Type: Short Peripheral Intravenous Catheters, Integrated/Closed Peripheral Intravenous Catheters (PIVC)
2) By Technology: Conventional Peripheral Intravenous Catheters (PIVC), Safety Peripheral Intravenous Catheters (PIVC)
3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare

Key Driver - Growing Prevalence Of Chronic Diseases Drives Expansion Of The Peripheral Iv Catheters Market

The rising prevalence of chronic diseases is expected to propel the growth of the peripheral IV catheters market. Peripheral intravenous catheters are commonly used in the management of various chronic diseases such as cancer, cardiovascular diseases, and others. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based self-governing statutory entity in charge of gathering and analyzing information as well as factual proposals, almost half of the population (46.6%, or 11.6 million) had a minimum of one chronic illness. The most common chronic conditions were mental and behavioral problems (20.1%), back pain (15.7%), and arthritis (12.5%). Therefore, the rising prevalence of chronic diseases is expected to propel the growth of the peripheral IV catheters market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=6658&type=smp

Prominent Trend - Technological Advancements Reshaping The Peripheral Iv Catheters Market Enhanced Safety And Efficiency

Technological advancements are shaping the peripheral IV catheters market. Many companies in the market are developing new products to provide technically enhanced products to their users. B. Braun Medical, a US-based infusion therapy company, launched the new Introcan Safety 2 IV cathetar with one-time blood control. The new product makes the IV access safer for clinicians by reducing the risk of needlestick injuries.

Peripheral IV Catheters Market Players
Major companies operating in the peripheral iv catheters market include Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical Inc., Vygon SAS, Terumo Corporation, Teleflex Incorporated, NIPRO Medical Corporation, Argon Medical Devices Inc., Medical Components Inc., Vascular Pathways Inc., Tangent Medical Technologies Inc., Vigmed AB, Venner Medical, C. R. Bard Inc., MedSource Labs, Intra Special Catheters GmbH, Greiner Bio-One International GmbH, Ares Medikal, Ace Medical Company, Heka s.r.l, Raumedic AG, Vogt Medical Vertrieb GmbH, RenovoRx Inc., Retractable Technologies Inc., AngioDynamics Inc., ICU Medical Inc., Medtronic plc, Edwards Lifesciences Corporation, Cook Group Incorporated, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Merit Medical Systems Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the peripheral IV catheters market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral iv catheters market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Peripheral IV Catheters Market Report Structure
3. Peripheral IV Catheters Market Trends And Strategies
4. Peripheral IV Catheters Market - Macro Economic Scenario
5. Peripheral IV Catheters Market Size And Growth
…..
27. Peripheral IV Catheters Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.